| UniProt ID | TLE2_HUMAN | |
|---|---|---|
| UniProt AC | Q04725 | |
| Protein Name | Transducin-like enhancer protein 2 | |
| Gene Name | TLE2 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 743 | |
| Subcellular Localization | Nucleus. | |
| Protein Description | Transcriptional corepressor that binds to a number of transcription factors. Inhibits the transcriptional activation mediated by CTNNB1 and TCF family members in Wnt signaling. The effects of full-length TLE family members may be modulated by association with dominant-negative AES (By similarity).. | |
| Protein Sequence | MYPQGRHPTPLQSGQPFKFSILEICDRIKEEFQFLQAQYHSLKLECEKLASEKTEMQRHYVMYYEMSYGLNIEMHKQAEIVKRLSGICAQIIPFLTQEHQQQVLQAVERAKQVTVGELNSLIGQQLQPLSHHAPPVPLTPRPAGLVGGSATGLLALSGALAAQAQLAAAVKEDRAGVEAEGSRVERAPSRSASPSPPESLVEEERPSGPGGGGKQRADEKEPSGPYESDEDKSDYNLVVDEDQPSEPPSPATTPCGKVPICIPARRDLVDSPASLASSLGSPLPRAKELILNDLPASTPASKSCDSSPPQDASTPGPSSASHLCQLAAKPAPSTDSVALRSPLTLSSPFTTSFSLGSHSTLNGDLSVPSSYVSLHLSPQVSSSVVYGRSPVMAFESHPHLRGSSVSSSLPSIPGGKPAYSFHVSADGQMQPVPFPSDALVGAGIPRHARQLHTLAHGEVVCAVTISGSTQHVYTGGKGCVKVWDVGQPGAKTPVAQLDCLNRDNYIRSCKLLPDGRSLIVGGEASTLSIWDLAAPTPRIKAELTSSAPACYALAVSPDAKVCFSCCSDGNIVVWDLQNQTMVRQFQGHTDGASCIDISDYGTRLWTGGLDNTVRCWDLREGRQLQQHDFSSQIFSLGHCPNQDWLAVGMESSNVEILHVRKPEKYQLHLHESCVLSLKFASCGRWFVSTGKDNLLNAWRTPYGASIFQSKESSSVLSCDISRNNKYIVTGSGDKKATVYEVVY | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 12 (in isoform 2) | Phosphorylation | - | 46.87 | 22210691 | |
| 13 (in isoform 2) | Phosphorylation | - | 47.26 | 22210691 | |
| 29 | Ubiquitination | LEICDRIKEEFQFLQ HHHHHHHHHHHHHHH | 52.68 | - | |
| 53 | Ubiquitination | CEKLASEKTEMQRHY HHHHHCCCHHHHHHH | 47.49 | - | |
| 68 | Phosphorylation | VMYYEMSYGLNIEMH HHHHHHHHCCCCHHH | 25.07 | 58505 | |
| 82 | Ubiquitination | HKQAEIVKRLSGICA HHHHHHHHHHHHHHH | 53.97 | - | |
| 182 | Phosphorylation | AGVEAEGSRVERAPS CCCCCCCCCCCCCCC | 25.34 | - | |
| 191 | Phosphorylation | VERAPSRSASPSPPE CCCCCCCCCCCCCCH | 37.12 | 24719451 | |
| 193 | Phosphorylation | RAPSRSASPSPPESL CCCCCCCCCCCCHHH | 27.45 | 26657352 | |
| 195 | Phosphorylation | PSRSASPSPPESLVE CCCCCCCCCCHHHCC | 51.06 | 26657352 | |
| 199 | Phosphorylation | ASPSPPESLVEEERP CCCCCCHHHCCCCCC | 43.41 | 24719451 | |
| 207 | Phosphorylation | LVEEERPSGPGGGGK HCCCCCCCCCCCCCC | 64.93 | 23312004 | |
| 223 | Phosphorylation | RADEKEPSGPYESDE CCCCCCCCCCCCCCC | 54.19 | 25278378 | |
| 226 | Phosphorylation | EKEPSGPYESDEDKS CCCCCCCCCCCCCCC | 31.43 | 25278378 | |
| 228 | Phosphorylation | EPSGPYESDEDKSDY CCCCCCCCCCCCCCC | 40.22 | 21815630 | |
| 233 | Phosphorylation | YESDEDKSDYNLVVD CCCCCCCCCCCEECC | 58.61 | 25278378 | |
| 235 | Phosphorylation | SDEDKSDYNLVVDED CCCCCCCCCEECCCC | 19.93 | 25278378 | |
| 245 | Phosphorylation | VVDEDQPSEPPSPAT ECCCCCCCCCCCCCC | 58.04 | 25278378 | |
| 249 | Phosphorylation | DQPSEPPSPATTPCG CCCCCCCCCCCCCCC | 37.57 | 25278378 | |
| 252 | Phosphorylation | SEPPSPATTPCGKVP CCCCCCCCCCCCCCC | 34.35 | 25278378 | |
| 253 | Phosphorylation | EPPSPATTPCGKVPI CCCCCCCCCCCCCCE | 20.77 | 25278378 | |
| 271 | Phosphorylation | ARRDLVDSPASLASS CCHHHCCCHHHHHHH | 18.19 | 26055452 | |
| 274 | Phosphorylation | DLVDSPASLASSLGS HHCCCHHHHHHHHCC | 28.05 | 28464451 | |
| 277 | Phosphorylation | DSPASLASSLGSPLP CCHHHHHHHHCCCCH | 31.24 | 23909892 | |
| 278 | Phosphorylation | SPASLASSLGSPLPR CHHHHHHHHCCCCHH | 31.01 | 22210691 | |
| 281 | Phosphorylation | SLASSLGSPLPRAKE HHHHHHCCCCHHHHH | 28.67 | 26055452 | |
| 287 | Ubiquitination | GSPLPRAKELILNDL CCCCHHHHHHHHHCC | 55.09 | - | |
| 297 | Phosphorylation | ILNDLPASTPASKSC HHHCCCCCCCCHHCC | 32.74 | 28555341 | |
| 298 | Phosphorylation | LNDLPASTPASKSCD HHCCCCCCCCHHCCC | 25.61 | 21815630 | |
| 301 | O-linked_Glycosylation | LPASTPASKSCDSSP CCCCCCCHHCCCCCC | 26.72 | 28657654 | |
| 301 | Phosphorylation | LPASTPASKSCDSSP CCCCCCCHHCCCCCC | 26.72 | 28348404 | |
| 303 | Phosphorylation | ASTPASKSCDSSPPQ CCCCCHHCCCCCCCC | 22.21 | 23312004 | |
| 306 | Phosphorylation | PASKSCDSSPPQDAS CCHHCCCCCCCCCCC | 49.42 | 28348404 | |
| 307 | Phosphorylation | ASKSCDSSPPQDAST CHHCCCCCCCCCCCC | 27.61 | 28348404 | |
| 313 | Phosphorylation | SSPPQDASTPGPSSA CCCCCCCCCCCCCCH | 43.34 | 23312004 | |
| 314 | Phosphorylation | SPPQDASTPGPSSAS CCCCCCCCCCCCCHH | 33.70 | 23312004 | |
| 318 | Phosphorylation | DASTPGPSSASHLCQ CCCCCCCCCHHHHHH | 44.44 | 23312004 | |
| 319 | Phosphorylation | ASTPGPSSASHLCQL CCCCCCCCHHHHHHH | 36.60 | 23312004 | |
| 321 | Phosphorylation | TPGPSSASHLCQLAA CCCCCCHHHHHHHHC | 20.95 | 28464451 | |
| 334 | O-linked_Glycosylation | AAKPAPSTDSVALRS HCCCCCCCCCCEECC | 31.10 | 28657654 | |
| 389 | Phosphorylation | SSVVYGRSPVMAFES CCEECCCCCEEEECC | 19.92 | 28555341 | |
| 477 | Ubiquitination | QHVYTGGKGCVKVWD EEEEECCCCEEEEEE | 50.94 | - | |
| 481 | Ubiquitination | TGGKGCVKVWDVGQP ECCCCEEEEEECCCC | 41.50 | - | |
| 491 | Ubiquitination | DVGQPGAKTPVAQLD ECCCCCCCCCCHHEE | 60.31 | - | |
| 492 | Phosphorylation | VGQPGAKTPVAQLDC CCCCCCCCCCHHEEC | 23.59 | 29632367 | |
| 505 | Phosphorylation | DCLNRDNYIRSCKLL ECCCCCCCHHHCEEC | 11.29 | 29632367 | |
| 508 | Phosphorylation | NRDNYIRSCKLLPDG CCCCCHHHCEECCCC | 13.17 | 29632367 | |
| 510 | Ubiquitination | DNYIRSCKLLPDGRS CCCHHHCEECCCCCE | 55.06 | - | |
| 540 | Ubiquitination | AAPTPRIKAELTSSA CCCCCCCEEEECCCC | 36.77 | - | |
| 569 | Ubiquitination | CFSCCSDGNIVVWDL EEEECCCCCEEEEEC | 14.96 | 21890473 | |
| 665 | Phosphorylation | HVRKPEKYQLHLHES EECCCCCEEEEEECH | 18.04 | 26699800 | |
| 672 | Phosphorylation | YQLHLHESCVLSLKF EEEEEECHHHHEEEE | 9.97 | 26699800 | |
| 676 | Phosphorylation | LHESCVLSLKFASCG EECHHHHEEEECCCC | 14.76 | 26699800 | |
| 681 | Phosphorylation | VLSLKFASCGRWFVS HHEEEECCCCCEEEE | 21.90 | 24719451 | |
| 691 | Acetylation | RWFVSTGKDNLLNAW CEEEECCHHHHHHHH | 43.46 | 30797605 | |
| 691 | Ubiquitination | RWFVSTGKDNLLNAW CEEEECCHHHHHHHH | 43.46 | 21890473 | |
| 695 (in isoform 3) | Phosphorylation | - | 5.29 | 26503514 | |
| 703 (in isoform 3) | Phosphorylation | - | 17.66 | 26503514 | |
| 710 | Ubiquitination | GASIFQSKESSSVLS CCHHCCCCCCCCCEE | 51.32 | - | |
| 712 | Phosphorylation | SIFQSKESSSVLSCD HHCCCCCCCCCEEEE | 31.48 | - | |
| 725 | Ubiquitination | CDISRNNKYIVTGSG EECCCCCEEEEECCC | 39.64 | - | |
| 726 | Phosphorylation | DISRNNKYIVTGSGD ECCCCCEEEEECCCC | 11.62 | - | |
| 729 | Phosphorylation | RNNKYIVTGSGDKKA CCCEEEEECCCCCEE | 18.97 | - | |
| 731 | Phosphorylation | NKYIVTGSGDKKATV CEEEEECCCCCEEEE | 34.16 | - | |
| 734 | Ubiquitination | IVTGSGDKKATVYEV EEECCCCCEEEEEEE | 48.08 | - |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
| 228 | S | Phosphorylation | Kinase | CK2 | - | Uniprot |
| 249 | S | Phosphorylation | Kinase | CDK1 | P06493 | Uniprot |
| 253 | T | Phosphorylation | Kinase | CDK1 | P06493 | Uniprot |
| - | K | Ubiquitination | E3 ubiquitin ligase | XIAP | P98170 | PMID:22199232 |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of TLE2_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TLE2_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| TLE2_HUMAN | TLE2 | physical | 9874198 | |
| TLE1_HUMAN | TLE1 | physical | 9874198 | |
| VENTX_HUMAN | VENTX | physical | 20211142 | |
| TLX3_HUMAN | TLX3 | physical | 20211142 | |
| BARH1_HUMAN | BARHL1 | physical | 20211142 | |
| LEF1_HUMAN | LEF1 | physical | 15768032 | |
| ORF50_HHV8P | ORF50 | physical | 19939918 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-271 AND SER-281, ANDMASS SPECTROMETRY. | |